Daily non-political popular news in brief.
New classification better identifies prostate cancer patients to benefit from hormone therapy
11-08-2006 · EurekAlert!A new classification system for evaluating men after radiation treatment for prostate cancer better determines which men may recur and thus may benefit from hormone therapy. Doctors applied the new system to 1,831 previously treated patients. The new classification could alter the course of treatment, which may include hormone therapy sooner and for more men. The study demonstrates a significant improvement in predicting endpoints, including distant metastasis, cause-specific mortality and overall mortality.
Read more »
Keywords: classification, identifies, prostate, cancer, patients, benefit, hormone, therapy, identify, patient
« Previous | Next »
Similar news on "New classification better identifies prostate cancer patients to benefit from hormone therapy":
- Gene's activity points to more lethal subtype of AML
07-09-2007 · EurekAlert!
A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy. The gene, called ERG (for ETS-related gene), has also been linked to chronic leukemia and to breast and prostate cancer.
Similar news · Read more »
- Study identifies women with breast cancer most likely to benefit from aromatase inhibitor
10-23-2006 · EurekAlert!
While some breast cancer survivors could benefit from adding aromatase inhibitors to the standard five years of tamoxifen, a new study shows the additional therapy should be weighed carefully for each individual. Tthe study's authors say potential improvement in cancer-free survival beyond five years with the added therapy may be less than two percent for most patients.
Similar news · Read more »
- Combination therapy improves survival for certain prostate cancer patients
01-22-2008 · EurekAlert!
Men with localized prostate cancer who were treated with male hormone suppression therapy and radiation treatment had longer survival, but those with moderate to high levels of other illnesses did not experience this effect, according to a study in the Jan. 23 issue of JAMA.
Similar news · Read more »
- More than 6 months of hormone therapy doesn't help prostate cancer patients live longer
11-05-2006 · EurekAlert!
Prostate cancer patients treated with either radiation or surgery who use hormone therapy for longer than six months do not survive any longer than patients who use the treatment for a shorter amount of time, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- Not just a menopausal symptom -- men have hot flashes, too
04-13-2007 · EurekAlert!
A new study in Psychophysiology confirms a surprising fact -- men who have undergone chemical castration for conditions such as prostate cancer experience hot flashes similar to those experienced by menopausal women. Using a technique called sternal skin conductance, doctors were able to positively identify hot flashes in males, a positive step toward providing therapy for those patients in need.
Similar news · Read more »
- Study: Not just a menopausal symptom -- men have hot flashes, too
04-13-2007 · EurekAlert!
A new study in Psychophysiology confirms a surprising fact -- men who have undergone chemical castration for conditions such as prostate cancer experience hot flashes similar to those experienced by menopausal women. Using a technique called sternal skin conductance, doctors were able to positively identify hot flashes in males, a positive step toward providing therapy for those patients in need.
Similar news · Read more »
- Measuring calcium intake can help to identify osteoporosis in men with prostate cancer
04-10-2007 · EurekAlert!
Study of 372 men with prostate cancer shows higher than average link with osteoporosis, regardless of whether hormone therapy or surgery is used. 49 percent of men had osteoporosis and only seven percent consumed recommended daily intake of calcium.
Similar news · Read more »
- Novel test identifies leukemia patients likely to respond to new therapy
02-20-2007 · EurekAlert!
Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.
Similar news · Read more »
- How can we know early who will benefit from tumor target therapy?
11-21-2007 · EurekAlert!
A 55-year-old male patient had developed advanced hepatic metastasis and peritoneal carcinomatosis after remnant gastric cancer resection three months earlier. The patient only received target therapy, including Cetuximab plus recombinant human endostatin treatment. Anti-tumor activity assessed by 18F-fluorodeoxyglucose positron emission tomography/computer tomography scan at baseline, then every four weeks afterward showed that 18FDG-PET/CT could make an early prediction of the response to cetuximab plus Endostar in such clinical situations.
Similar news · Read more »
- Personalized diets may offer relief to advanced cancer patients
03-09-2007 · EurekAlert!
Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
Similar news · Read more »
